Cold-adapted influenza and recombinant adenovirus vaccines induce cross-protective immunity against pH1N1 challenge in mice.
about
Advances and future challenges in recombinant adenoviral vectored H5N1 influenza vaccinesCross-Allele Cytotoxic T Lymphocyte Responses against 2009 Pandemic H1N1 Influenza A Virus among HLA-A24 and HLA-A3 Supertype-Positive IndividualsNonreplicating influenza A virus vaccines confer broad protection against lethal challengePre-clinical evaluation of a replication-competent recombinant adenovirus serotype 4 vaccine expressing influenza H5 hemagglutininMucosal immunization with a candidate universal influenza vaccine reduces virus transmission in a mouse model.Memory T cells generated by prior exposure to influenza cross react with the novel H7N9 influenza virus and confer protective heterosubtypic immunity.Viral vector-based influenza vaccines.Antibodies against conserved antigens provide opportunities for reform in influenza vaccine designRecombinant parainfluenza virus 5 vaccine encoding the influenza virus hemagglutinin protects against H5N1 highly pathogenic avian influenza virus infection following intranasal or intramuscular vaccination of BALB/c mice.Experimental vaccines against potentially pandemic and highly pathogenic avian influenza virusesSubsisting H1N1 influenza memory responses are insufficient to protect from pandemic H1N1 influenza challenge in C57BL/6 mice.Intranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice.Virus-vectored influenza virus vaccines.Vaccination with M2e-based multiple antigenic peptides: characterization of the B cell response and protection efficacy in inbred and outbred mice.Increased immunogenicity and protective efficacy of influenza M2e fused to a tetramerizing proteinRobust immunity and heterologous protection against influenza in mice elicited by a novel recombinant NP-M2e fusion protein expressed in E. coliMucosal vaccination with recombinant adenovirus encoding nucleoprotein provides potent protection against influenza virus infection.Protective Efficacy of the Conserved NP, PB1, and M1 Proteins as Immunogens in DNA- and Vaccinia Virus-Based Universal Influenza A Virus Vaccines in Mice.Age Dependence of Immunity Induced by a Candidate Universal Influenza Vaccine in MiceRecombinant parainfluenza virus 5 expressing hemagglutinin of influenza A virus H5N1 protected mice against lethal highly pathogenic avian influenza virus H5N1 challenge.Single-dose vaccination of a recombinant parainfluenza virus 5 expressing NP from H5N1 virus provides broad immunity against influenza A viruses.Comparison of the effectiveness of antibody and cell-mediated immunity against inhaled and instilled influenza virus challenge.A novel influenza virus hemagglutinin-respiratory syncytial virus (RSV) fusion protein subunit vaccine against influenza and RSVNovel H7N9 influenza virus shows low infectious dose, high growth rate, and efficient contact transmission in the guinea pig model
P2860
Q27013568-D9C38C99-C289-4E76-BE2E-4D4483297A71Q27673689-36475316-F6EA-4B8B-AE7E-0B10BBAF44D6Q28392109-BF7452D8-35D8-44F8-A9E9-3CBEEF56EF50Q28731982-2F6E56E1-DBAC-404B-957A-2C256CFCEB9BQ30360144-02CBB364-0FE2-4D78-8DE4-C9033A5CB65CQ30371653-0590C8FF-CBAC-462C-852B-F46AAA5D7C83Q30390938-8226D313-0A78-471F-996B-9B777EBFAA27Q30416502-B3A8D0EB-C5D8-4DE2-AAAF-76A329A458D7Q30422513-176F5302-7CC3-46BC-83A6-E2EACA5402A3Q30427591-01566440-E3E3-4BA3-B53B-7908DFFB1D3AQ30429302-AF2F00B6-AA01-4AA4-9C23-7C8215CD42C7Q34059627-25AA638D-149B-4BF5-BABF-6BC628AD3E34Q34102268-E7E2115F-518E-4F2C-8A58-FFA7E620BB1CQ34105207-D6EF32FA-E8D8-4EEF-AC81-2958304AABB0Q34437654-510ED655-29F0-43A8-BB44-F41B1E4D648DQ34533990-4AAF0FF1-7B84-45E6-8656-D6CE3B0A6F15Q35005641-DACE7615-F909-499E-850D-CA7FFA3A7CCFQ35656657-0EE6242D-2683-44B9-864B-EAFA8C15025BQ35982805-42491EAA-DE95-4B10-BD3B-DE8690B88191Q36506905-F594C32C-5EA1-45DE-ABD0-7D44AC9E170BQ36827388-17484D73-55E9-4F6B-98CA-A773F684BCF3Q36952551-7394080E-8F56-4593-AB7A-8D6E69FFC02DQ37252918-CFBCE18C-68D2-4FCD-899D-A84124FBC98AQ37547355-D5E8D245-EAA4-4367-9EB9-44D8A374B928
P2860
Cold-adapted influenza and recombinant adenovirus vaccines induce cross-protective immunity against pH1N1 challenge in mice.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cold-adapted influenza and rec ...... ainst pH1N1 challenge in mice.
@ast
Cold-adapted influenza and rec ...... ainst pH1N1 challenge in mice.
@en
type
label
Cold-adapted influenza and rec ...... ainst pH1N1 challenge in mice.
@ast
Cold-adapted influenza and rec ...... ainst pH1N1 challenge in mice.
@en
prefLabel
Cold-adapted influenza and rec ...... ainst pH1N1 challenge in mice.
@ast
Cold-adapted influenza and rec ...... ainst pH1N1 challenge in mice.
@en
P2093
P2860
P1433
P1476
Cold-adapted influenza and rec ...... ainst pH1N1 challenge in mice.
@en
P2093
Chia-Yun Lo
Graeme E Price
Jianqiang Ye
Jon D Gabbard
Julia A Misplon
Mark R Soboleski
S Mark Tompkins
Suzanne L Epstein
P2860
P304
P356
10.1371/JOURNAL.PONE.0021937
P407
P577
2011-07-15T00:00:00Z